A 66-year-old man whose renal function had progressively deteriorated had an elevated blood pressure and also was found to have an inflammatory abdominal aortic aneurysm (AAA). Blood examination revealed that he had eosinophilia. Livedo reticularis of the toes developed, and a skin biopsy specimen showed embolization of atheromatous plaques in the arterioles of the subcutaneous tissue. Progressive enlargement of inflammatory AAAmay have dislodged the atheromatous plaques, resulting in cholesterol embolism. (Internal Medicine 38: 861-864, 1999) 
Introduction
There is growing awareness concerning cholesterol embolism as a complication of intravascular catheterization and anticoagulant or thrombolytic therapy, in which atheromatous materials are dislodged from major vascular walls and occlude small arteries of multiple organs (1-7). The organs affected by cholesterol embolism depend on the site where atheromatous plaques are dislodged. Frequently involved organs include the kidneys and skin, and the resulting renal failure is often severe or fatal (1, 2, 6, 7) . Wepresent here, a case of cholesterol embolism that presumably developed due to enlargement of an inflammatory abdominal aortic aneurysm (AAA).
Case Report
A 66-year-old man was referred to our hospital on April 2, 1998, due to a pulsatile abdominal mass and progressive deterioration of renal function accompanied by elevated blood pressure. According to his medical records, he was normotensive and the serum creatinine level was 1.3 mg/dl on December 5, 1997, but it rose to 3.3 mg/dl on March 17. The patient noticed an abdominal mass at the beginning of 1998, and it had progressively become enlarged. Diet and exercise therapy had been recommendedfor diabetes mellitus since 1989 and he suffered from cerebral infarction in 1988. On physical examination, his blood pressure was 188/108 mmHgand the pulse rate was 82 per minute. The pulse of the left dorsalis pedis artery was weaker than the right, but no skin abnormality was found. The chest was clear to percussion and auscultation. Palpation of the abdomenrevealed a well-defined pulsatile mass of 5 cm in diameter at the middle of the abdomen, while no bruit was audible. Neither hemiparesis nor exaggerated reflexes were noted on neurological examination. Table 1 summarizes the laboratory data on admission. Urinalysis showed 2+ for protein and 1 or 2 granular casts per highpower field were seen. The hemoglobin was 10.8 g/dl, and the white blood cell count was slightly increased to 10,500 per jil without elevation of the eosinophil count. The serum creatinine and urea nitrogen levels showeddeterioration of renal function. Endocrinological test revealed increased plasma renin activity with elevation of the aldosterone level. No marked findings were observed by chest X-ray or electrocardiography.
Abdominal computed tomography (CT) revealed an enlarged abdominal aorta with a diameter of 6 cmaccompanied by calcification, mural thrombus formation, and thickened adventitia ( Fig. 1) . Renography showed bilateral impairment of renal function ( Fig. 2A) , and diffuse reduction of radioisotope uptake was noted by scintigram (Fig. 2B ). After admission, both (3-adrenergic blocker and calcium channel antagonist were administered, and his blood pressure was controlled at a level of 120/80 mmHg.On the fourth day of hospitalization, the eosinophil count in peripheral blood increased to a level of 1,040 per |il and livedo reticularis developed bilaterally in the toes (Fig. 3A) . Whereas, based on the findings of CT and magnetic resonance imaging (MRI) as well as ultrasound, the strict blood pressure control appeared to prevent the AAAfrom enlarging further after admission. Discon- tinuation of ticlopidine, which he had been taking since 1988, had no effect on the skin lesion or eosinophilia. Histologic examination of the biopsy specimen of the toe skin showed biconvex, needle-shaped cholesterol clefts accompanying the intimal reaction in arterioles of the subcutaneous tissue (Fig.   3B ).
Since, in addition to the size, AAAwassuspected as a site where atheromatous plaques dislodged, the patient underwent insertion of a Y-shaped graft into the abdominal aorta on June 4. Inflammatory adhesion of the enlarged abdominal aorta to the surrounding retroperitoneal tissue was seen, and the aortic wall thickened. The luminal side showed marked atherosclerosis accompanied by extensive ulceration and mural thrombus, which was observed from the site distal to the ostia of renal arteries to bifurcation of commoniliac arteries. Histopathological examination of the aorta revealed that the thickened adventitia consisted of dense fibrous connective tissue Aortic Aneurysmand Cholesterol Embolism with lymphoplasmacytic infiltrate, a finding compatible with inflammatory AAA.After the operation, the increased eosinophil count decreased from 1,500 to 500 per fil, and the renal function did not further deteriorate during his hospital stay.
Discussion
Cholesterol embolismhas recently been recognized as a severe complicationof catheterization procedures or anticoagulant therapy (1-7). Organs often affected by cholesterol embolism include the kidneys, spleen, skin, pancreas and intestine (1, 2, 6, 7). Amongthem, renal involvement is relatively frequent and often fatal (1, 6, 7) . Dislodgment of atheromatousplaques from the major arteries has been knownto occur following mechanical manipulation by intravascular catheterization or anticoagulation therapy (3) (4) (5) . In the present case, no such primary cause was noted, except for ticlopidine. This anti-platelet medicine may be partially involved in the development of cholesterol embolism; however, it is unlikely a primary factor, because the patient had been administered ticlopidine since he suffered from cerebral infarction 10 years previou sly.
Based on the findings of abdominal CT and MRI (8) , inflammatory AAAwas suspected in this case, and the histological examination revealed infiltration of chronic inflammatory cells into the thickened adventitia of the aneurysmal wall. There was no evidence of underlying diseases, which are knownto cause inflammation of the aorta, such as retroperitoneal fibrosis, Behcet's disease, bacterial infection or aortitis syndrome in our patient (9) . Keen et al reported that small aortoiliac aneurysms were identified as possible atheroembolic sources in 20 of 100 patients with cholesterol embolism (10) . Whereas, to the best of our knowledge, no previous study has shown a direct association between cholesterol embolism and progressive enlargement of AAAincluding inflammatory aneurysm. Since mechanicalmanipulation of the vascular wall is a commoncause of cholesterol embolism, stretching of the atherosclerotic aorta by enlarging AAAmay result in dislodgment of the atheromatous plaque from the aortic wall.
In the present case, deterioration of renal function occurred in association with AAAenlargement. Renography showed that the renal function was equally impaired bilaterally, and a diffuse reduction of radioisotope uptake was seen by scintigram. Twomechanisms may account for the deteriorated renal function: insufficient blood supply to the kidneys and cholesterol embolism. Compression of renal arteries may have occurred due to enlargement ofAAA,and in fact, the plasma renin activity was elevated on admission. Furthermore, renal failure is one of the most frequent complications of cholesterol embolism (1, 6, 7). There was no marked symptom of livedo reticularis in this patient and he did not notice this condition before admission, but the cholesterol embolism may have caused the reduced renal function. In summary, we reported a case of cholesterol embolism that was likely secondary to AAAenlargement. It remains unclear whether deterioration of renal function wasattributed to the cholesterol embolism; however, cholesterol embolism may develop due to AAAenlargement.
